Nicola Long

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia”.

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1916206117

N/A

0DataRank · unranked

105 citations

Yoko Kosaka, Ted Laderas, Allie Maffit, Andy Kaempf, Lauren Brady +17 more

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

0DataRank · unranked

373 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0745

N/A

0DataRank · unranked

8 citations

Brittany M. Curtiss, Daniel J. Coleman, Jake VanCampen, Garth Kong, Jommel Macaraeg +10 more

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia

Frontiers in Oncology(2023)10.3389/fonc.2023.1192829

N/A

0DataRank · unranked

1 citations

Daniel Bottomly, William M. Yashar, Nicola Long, Matthew Viehdorfer, Shannon K. McWeeney +2 more

Impact of Germline CHEK2 Pathogenic Variants on the Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-25-1074

N/A

0DataRank · unranked

1 citations

Nicola Long, Jonathan C. Savage, Jose M. Solis-Ruiz, Y. Li, Angela C. Holt +7 more

CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102526

N/A

0DataRank · unranked

1 citations

Jessica Gibbs, Kevin Watanabe‐Smith, Ariel H. Nguyen, Isabel Kenna, Karina Thiel-Klare +12 more

A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.08.681215

N/A

0DataRank · unranked

0 citations

Christopher A. Eide, Andy Kaempf, Nicola Long, Alexandria Miller, Daniel Bottomly +8 more